جدول الترويج PureTech Health plc
الجدول الزمني المتقدم
رسم بياني بسيط
عن الشركة PureTech Health plc
PureTech Health plc, a clinical stage biotherapeutics company, engages in the discovery, development, and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, currently under Phase 3 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, to inhibit the activity of galectin-9 for treating solid tumors and hematological malignancies. مزيد من التفاصيل| IPO date | 2020-11-16 |
|---|---|
| ISIN | US7462371060 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://www.puretechhealth.com |
| Цена ао | 16.75 |
| تغير السعر يوميا: | -0.4407% (17.7) |
|---|---|
| تغير السعر في الأسبوع: | +5.47% (16.7088) |
| تغير السعر شهريا: | -6.71% (18.89) |
| تغير السعر خلال 3 أشهر: | -9.68% (19.51) |
| تغير السعر على مدى ستة أشهر: | -14.52% (20.615) |
| تغير السعر سنويا: | -38.17% (28.5) |
| تغير السعر على مدى 3 سنوات: | -38.77% (28.78) |
| تغير الأسعار منذ بداية العام: | -11.54% (19.92) |
|
|
الاستهانة
|
كفاءة
|
|||||||||||||||||||||||||||||||||||||
توزيعات الأرباح
|
واجب
|
دافع النمو
|
|||||||||||||||||||||||||||||||||||||
| المؤسسات | مقدار | يشارك, % |
|---|---|---|
| Pentwater Capital Management LP | 10244 | 0.04 |
| Tower Research Capital LLC (TRC) | 43 | 0 |
| UBS Group AG | 20 | 0 |
| ETF | يشارك, % | الربحية لهذا العام, % | توزيعات الأرباح, % |
|---|---|---|---|
| Amplify BlueStar Israel Technology ETF | 0.30643 | 20.42 | 0.47569 |
| Invesco Global Listed Private Equity ETF | 0.29338 | 29.43 | 3.4983 |
| Dimensional International Small Cap ETF | 0.02653 | 5.69 | 3.34747 |
| SPDR S&P International Small Cap ETF | 0.0233 | 8.94 | 3.10348 |
| Schwab International Small-Cap Equity ETF | 0.0133 | 10.07 | 3.20638 |
| SPDR Portfolio Europe ETF | 0.00347 | 8.94 | 3.66537 |
| Dimensional International Core Equity 2 ETF | 0.00136 | 6.52 | 3.69996 |
| Avantis International Equity ETF | 0.00099 | 6.46 | 3.80856 |
| Dimensional International Core Equity Market ETF | 0.00032 | 13.09 | 3.48343 |
Vanguard FTSE All-World ex-US Small-Cap ETF
|
0 | 9.39 | 3.09932 |
| Vanguard ESG International Stock ETF | 0 | 6.39 | 3.07501 |
| 0.06 | 11.39 | 3.13 |
| مشرف | مسمى وظيفي | قسط | سنة الميلاد |
|---|---|---|---|
| Ms. Daphne Zohar | Founder, Senior Advisor & Board Observer | 3.99M | 1971 (54 سنة) |
| Dr. Bharatt M. Chowrira J.D., Ph.D. | CEO & Executive Director | 2.19M | 1965 (60 سنين) |
| Dr. David R. Elmaleh Ph.D. | Co-Founder & Senior Advisor | N/A | 1948 (77 سنين) |
| Ms. Allison Mead Talbot | Head of Communications & Investor Relations | N/A | |
| Mr. Spencer Ball | Senior Vice President of Human Resources | N/A | |
| Dr. Eric Elenko Ph.D. | Co-Founder & President | N/A | 1973 (52 سنة) |
| Mr. Eric Green M.B.A. | Chief Operating Officer | N/A | |
| Mr. Charles Sherwood III, J.D., Ph.D. | General Counsel & Company Secretary | N/A | |
| Dr. Robert S. Langer Jr., Ph.D., ScD | Co-Founder & Non-Executive Director | 1949 (76 سنين) | |
| Mr. Michael Inbar CPA, M.B.A. | Senior Vice President of Finance |
عنوان: United States, Boston. MA, 6 Tide Street - مفتوحة في خرائط جوجل, فتح خرائط ياندكس
موقع إلكتروني: https://www.puretechhealth.com
موقع إلكتروني: https://www.puretechhealth.com
